Your browser doesn't support javascript.
loading
The association of body mass index and body composition with plasma amyloid beta levels.
Hermesdorf, Marco; Esselmann, Hermann; Morgado, Barbara; Jahn-Brodmann, Anke; Herrera-Rivero, Marisol; Wiltfang, Jens; Berger, Klaus.
Afiliação
  • Hermesdorf M; Institute of Epidemiology and Social Medicine, University of Münster, Münster 48149, Germany.
  • Esselmann H; Department of Psychiatry, University Medical Center Göttingen, Goettingen 37075, Germany.
  • Morgado B; Department of Psychiatry, University Medical Center Göttingen, Goettingen 37075, Germany.
  • Jahn-Brodmann A; Department of Psychiatry, University Medical Center Göttingen, Goettingen 37075, Germany.
  • Herrera-Rivero M; Department of Genetic Epidemiology, Institute of Human Genetics, University of Münster, Münster 48149, Germany.
  • Wiltfang J; Department of Psychiatry, University of Münster, Münster 48149, Germany.
  • Berger K; Department of Psychiatry, University Medical Center Göttingen, Goettingen 37075, Germany.
Brain Commun ; 5(5): fcad263, 2023.
Article em En | MEDLINE | ID: mdl-37901043
ABSTRACT
Blood-based analysis of amyloid-ß is increasingly applied to incrementally establish diagnostic tests for Alzheimer's disease. To this aim, it is necessary to determine factors that can alter blood-based concentrations of amyloid-ß. We cross-sectionally analysed amyloid-ß-40 and amyloid-ß-42 concentrations and the 40/42 ratio in 440 community-dwelling adults and associations with body mass index, waist-to-height ratio and body composition assessed using bioelectrical impedance analysis. Body mass index and waist-to-height ratio were inversely associated with plasma amyloid-ß-42 concentrations. Body fat mass, but not body cell mass and extracellular mass, was inversely associated with amyloid-ß-42 levels. The results indicate that plasma concentrations of amyloid-ß-42 are lower in those with increased body mass index and body fat, and associations with amyloid-ß-40 did not reach significance after controlling for multiple testing. The findings support the use of body mass index as an easy-to-measure factor that should be accounted for in diagnostic models for plasma amyloid-ß.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Brain Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Brain Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha